24/7 Patient Assistance: 760-405-8205

Hospitals & Clinics

  • Bio & Insurance Information

    Dr. Kuang-Yu Jen is a pathologist from Sacramento, California. He is a board-certified practitioner in anatomic pathology and his sub-specialties are the renal pathology, transplantation immunology, and molecular genetics. Dr. Kuang-Yu Jen graduated from the Perelman University of Pennsylvania. Afterward, he completed a residency and a chief residency stage in anatomic pathology at the University of California, San Francisco. He completed two fellowship stages in renal pathology and surgical and transplant pathology at the same institution, UCSF, followed by a post-doctoral fellowship in cancer genetics. Dr. Jen has an extensive research experience; he published multiple studies in collaboration with other specialists. His research tackled some of the following topics: AA amyloidosis patients, malignant pleural mesotheliomas, radiation-induced tumor development, Kras-driven lung cancer, skin tumor progression, lung adenocarcinomas, renal allograft biopsies. Dr. Kuang-Yu Jen is currently affiliated with the University of California, Davis Medical Center.



  • Education & Training

    dept_icon

    Perelman the University of Pennsylvania

    Medical School

    dept_icon

    UCSF

    Residency

    dept_icon

    University of California at San Francisco

    Fellowship

    dept_icon

    UCSF

    Fellowship

  • Board Certifications

    American Board of Pathology

  • Hospital & Practice

    UCSF Medical Center

    Languages: English/Spanish

    (415) 353-1037

    505 Parnassus Ave

    San Francisco, California 94143

    Read More
  • Publications & Memberships

    Dr. Kuang-Yu Jen has contributed to 3 publications.

    Characteristics of AA amyloidosis patients in San Francisco.

    Lejmi, H.,Jen, K. Y.,Olson, J. L.,James, S. H.,Sam, R.,Lejmi, H.,Jen, K. Y.,Olson, J. L.,James, S. H.,Sam, R.; Nephrology (Carlton). 2015 Sep 16.

    See more >>

    Whole exome and targeted deep sequencing identify genome-wide allelic loss and frequent SETDB1 mutations in malignant pleural mesotheliomas.

    Kang HC, Kim HK, Lee S, Mendez P, Kim JW, Woodard G, Yoon JH, Jen KY, Fang LT, Jones K, Jablons DM, Kim IJ; Oncotarget. 2016 Feb 16.

    See more >>

    Evolution of metastasis revealed by mutational landscapes of chemically induced skin cancers.

    McCreery, M. Q.,Halliwill, K. D.,Chin, D.,Delrosario, R.,Hirst, G.,Vuong, P.,Jen, K. Y.,Hewinson, J.,Adams, D. J.,Balmain, A.; Nat. Med.. 2015 Nov 03.

    See more >>